Stock 300233 SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Shandong Jincheng Pharmaceutical Group Co., Ltd

Equities

300233

CNE100001500

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
14.2 CNY -1.18% Intraday chart for Shandong Jincheng Pharmaceutical Group Co., Ltd -2.07% -14.77%
Jul. 11 China Approves Changes to Shandong Jincheng's Antibiotic; Shares Up 3% MT
May. 17 Chinese Drug Regulator Gives Thumbs Up to Jincheng Pharmaceutical Unit's Application to Raise Cefadroxil Dry Suspension's Dosage MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China Approves Changes to Shandong Jincheng's Antibiotic; Shares Up 3%
MT
Chinese Drug Regulator Gives Thumbs Up to Jincheng Pharmaceutical Unit's Application to Raise Cefadroxil Dry Suspension's Dosage
MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023, Payable on May 8, 2024
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Shandong Jincheng Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on February 2, 2024.
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd's Equity Buyback announced on February 2, 2024, has closed with 4,543,000 shares, representing 1.18% for CNY 55 million.
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 70 million worth of its shares.
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jincheng Pharmaceutical Gets License to Produce E-Cigarette Nicotine
MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for 2022
CI
Three Jincheng Pharmaceutical Medicines Shortlisted For China’s Drug Procurement Program
MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Announces Final Profit Distribution Plan for 2021, Payable on May 11, 2022
CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300233 Stock
  4. News Shandong Jincheng Pharmaceutical Group Co., Ltd
  5. Highlights